Gisbert Javier P, Barreiro-de Acosta Manuel, Esteve María, García-Sánchez Valle, Gomollón Fernando, Guardiola Jordi, Hinojosa Joaquin, Martín Arranz Maria-Dolores, Minguez Miguel, Taxonera Carlos, Vera Isabel
*Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigacion Sanitaria Princesa (IIS-IP), Madrid, and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Spain; †Department of Gastroenterology, Hospital Clinico Universitario, Santiago de Compostela, Spain; ‡Department of Gastroenterology, Hospital Universitari Mutua de Terrassa, Barcelona, and CIBEREHD, Spain; §Department of Gastroenterology, Instituto Maimonides de Investigacion Biomedica de Cordoba (IMIBIC), Hospital Universitario Reina Sofia, Hospital Universitario Reina Sofia, Cordoba, Spain; ‖Department of Gastroenterology, Hospital Clinico Universitario Lozano Blesa, Zaragoza, and CIBEREHD, Spain; ¶Department of Gastroenterology, Hospital Universitario de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; **Department of Gastroenterology, Hospital de Manises, Valencia, Spain; ††Department of Gastroenterology, Hospital Universitario La Paz, Madrid, Spain; ‡‡Department of Gastroenterology, Hospital Clínico Universitario, Universitat de Valencia, Valencia, Spain; §§Department of Gastroenterology, Hospital Clinico San Carlos and Instituto de Investigacion del Hospital Clinico San Carlos (IdISSC), Madrid, Spain; and ‖‖Department of Gastroenterology and Hepatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Inflamm Bowel Dis. 2016 Mar;22(3):583-98. doi: 10.1097/MIB.0000000000000617.
There is still uncertainty about what constitutes the best therapeutic practice in ulcerative colitis (UC).
The purpose of the "UC Horizons Project" was to raise a series of questions regarding the management of UC to provide responses based on the best scientific evidence available.
The 11 members of the scientific committee prepared draft answers to the 10 questions from available evidence after a literature search. A total of 48 Spanish gastroenterology specialists nationwide participated in the project. The national meeting discussed the 10 issues in working groups and reached consensus regarding the recommendations by anonymous, interactive vote following the Delphi methodology. Final answers were developed, based on evidence and clinical experience of the participants.
All the recommendations achieved a high level of agreement in the plenary vote, although the quality of the evidence was markedly heterogeneous. The lowest percentage of agreement corresponded to the questions with the weakest level of evidence, highlighting the necessity of conducting further studies in these areas. The recommendations focused on (1) aminosalicylates therapy (regarding dose and appropriateness of coadministration with thiopurines), (2) corticosteroid therapy (regarding dose and route of administration), (3) thiopurine treatment (regarding indications and possibility of withdrawal), (4) anti-tumor necrosis factor therapy (regarding appropriateness of combination with thiopurines, intensification, or discontinuation of treatment), and (5) colorectal cancer (regarding risk and time trends).
The UC Horizons Project raised a series of eminently practical questions about the management of UC and provided responses based on the best scientific evidence available.
关于溃疡性结肠炎(UC)的最佳治疗方案仍存在不确定性。
“UC视野项目”旨在提出一系列关于UC管理的问题,并根据现有最佳科学证据给出答案。
科学委员会的11名成员在文献检索后,根据现有证据为10个问题准备了初步答案。全国共有48名西班牙胃肠病学专家参与了该项目。全国会议在工作组中讨论了这10个问题,并按照德尔菲法通过匿名交互式投票就建议达成了共识。最终答案是根据参与者的证据和临床经验制定的。
尽管证据质量明显参差不齐,但所有建议在全体投票中都达成了高度一致。一致率最低的问题对应的是证据水平最弱的问题,这突出了在这些领域进行进一步研究的必要性。这些建议集中在(1)氨基水杨酸类药物治疗(关于剂量以及与硫唑嘌呤联合使用的适宜性),(2)皮质类固醇治疗(关于剂量和给药途径),(3)硫唑嘌呤治疗(关于适应症和停药可能性),(4)抗肿瘤坏死因子治疗(关于与硫唑嘌呤联合使用、强化治疗或停药的适宜性),以及(5)结直肠癌(关于风险和时间趋势)。
“UC视野项目”提出了一系列关于UC管理的非常实际的问题,并根据现有最佳科学证据给出了答案。